会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Directional information delivery system and method
    • 定向信息传递系统及方法
    • US07555292B2
    • 2009-06-30
    • US11410488
    • 2006-04-25
    • Wei Kai XieYudong YangHang Jun YeTao Zhou
    • Wei Kai XieYudong YangHang Jun YeTao Zhou
    • H04Q7/22
    • H04B10/1149
    • A directional information delivery method and system, wherein a wide-angle electromagnetic wave transmitter is attached on each object for transmitting channel identification that indicates the transferring channel of the information of the exhibited item attached with the wide-angle electromagnetic wave transmitter to a specified area in wide angle, while each portable client device is provided with a directional electromagnetic wave receiver. When a user points the client device he/she to an object, it can receive the electromagnetic wave from that exhibited item. Then, the client device obtains a channel identification from that electromagnetic wave, and establishes a connection with an information delivery sub-system based on the obtained channel identification to obtain information about that exhibited item from the channel and to render that information. In this way, a user can select simply by pointing at the exhibited item with the client device, thereby accurately obtaining the information about the exhibited item of interest.
    • 一种定向信息传递方法和系统,其中广角电磁波发射器附着在每个物体上,用于传输信道识别,该信道标识指示附加有广角电磁波发射机的展示物品的信息的传送信道到指定区域 在广角范围内,而每个便携式客户端设备设置有定向电磁波接收器。 当用户将客户端设备指向对象时,可以从该展示项目接收电磁波。 然后,客户端装置从该电磁波获取信道识别,并且基于所获得的信道标识与信息传递子系统建立连接,以从信道获得关于所展示的项目的信息并呈现该信息。 以这种方式,用户可以简单地通过用客户端设备指示展示的项目,从而准确地获得关于所展示的感兴趣的项目的信息。
    • 5. 发明授权
    • Extraordinary magnetoresistance at room temperature in inhomogeneous narrow-gap semiconductors
    • 在非均匀窄间隙半导体中室温下的非凡磁阻
    • US06707122B1
    • 2004-03-16
    • US09697661
    • 2000-10-26
    • Daniel R. HinesStuart A. SolinTineke ThioTao Zhou
    • Daniel R. HinesStuart A. SolinTineke ThioTao Zhou
    • H01L2714
    • G11C11/14G01R33/09G01R33/095G11B5/37G11B5/398G11B5/3993H01L43/08Y10T428/1143Y10T428/12576Y10T428/12937
    • A symmetric van der Pauw disk of homogeneous nonmagnetic semiconductor material, such as indium antimonide, with an embedded concentric conducting material inhomogeneity, such as gold, exhits room temperature geometric extraordinary magnetoresistance (EMR) as high as 100%, 9,100% and 750,000% at magnetic fields of 0.05, 0.25 and 4.0 Tesla, respectively. Moreover, for inhomogeneities of sufficiently large cross section relative to that of the surrounding semiconductor material, the resistance of the disk is field-independent up to an onset field above which the resistance increases rapidly. These results can be understood in terms of the field-dependent deflection of current around the inhomogeneity. The EMR exhibited by a composite van der Pauw sensor comprising a semiconductor having an embedded metallic inhomogeneity or internal shunt can be obtained from electrically equivalent externally shunted structures, such as rectangular plates including an external conductive shunt element which is simple to manufacture in the mesoscopic sizes required for important magnetic sensor applications. For example, a bilinear conformal mapping is used to transform a circular composite van der Pauw disk sensor having an embedded conducting inhomogeneity into a corresponding externally shunted rectangular plate structure. The result is an EMR sensor that can be realized in very simple structures which facilitate fabrication in mesoscopic dimensions important for many magnetic sensor applications.
    • 均匀非磁性半导体材料的对称van der Pauw磁盘,如锑化铟,具有不均匀性的嵌入式同心导电材料,如金,可以将室温几何异常磁阻(EMR)高达100%,9,100%和750,000% 磁场分别为0.05,0.25和4.0特斯拉。 此外,对于相对于周围半导体材料的横截面足够大的不均匀性,磁盘的电阻是磁场独立的,直到电阻快速增加的起始场。 这些结果可以根据不均匀性周围的电流的场相关偏转来理解。 包括具有嵌入的金属不均匀性或内部分流的半导体的复合范德波湿传感器所展示的EMR可以从电等效的外部分流结构获得,例如包括外部导电分流元件的矩形板,该外部导电分流元件以介观尺寸制造简单 需要重要的磁传感器应用。 例如,双线性共形映射用于将具有嵌入的导电不均匀性的圆形复合材料van der Pauw盘传感器转换成相应的外部分流的矩形板结构。 结果是可以以非常简单的结构实现的EMR传感器,这有助于在许多磁传感器应用中重要的介观尺寸中的制造。
    • 7. 发明申请
    • MOLECULAR MARKER CUEDC2 PROTEIN FOR PROGNOSTIC DETERMINATION OF BREAST CANCER ENDOCRINOLOGY THERAPY
    • 分子标记CUEDC2蛋白质用于乳腺癌内分泌治疗的预后测定
    • US20140066604A1
    • 2014-03-06
    • US13981271
    • 2011-10-28
    • Xuemin ZhangTao ZhouXin PanHuiyan LiAiling Li
    • Xuemin ZhangTao ZhouXin PanHuiyan LiAiling Li
    • C07K16/18
    • C07K16/18C07K16/3015G01N33/57415G01N33/57449G01N2800/52
    • Disclosed is a use of the CUEDC2 protein in the preparation of diagnostic agents for prognostic determination of the endocrinology therapy for the breast cancer patients and for the diagnosis of tumor such as breast cancer and ovarian cancer. The diagnostic agent comprises an antibody against the CUEDC2 protein, wherein the antibody is a monoclonal or polyclonal antibody against the CUEDC2 protein. Provided is a kit or a composition for prognostic determination of endocrinology therapy for the breast cancer patients and for the diagnosis of tumors such as breast cancer and ovarian cancer. The kit or composition comprises an antibody against the CUEDC2 protein. Further disclosed is a use of the CUEDC2 gene or protein in preparation of drugs for treating tumors, that is, small molecular substances and specific antibodies that specifically inhibit the expression or activity of the CUEDC2 gene\protein are used as a therapeutic agent to restore the sensitivity of drug-resistant tumors to drug treatment. The new use of the CUEDC2 protein provides a new basis for determining a dosage regimen of adjuvant therapy after surgical operation of the breast cancer patients, thereby improving the therapeutic effect of the anti-cancer drugs and alleviating the suffering and economic burden of the patients.
    • 公开了使用CUEDC2蛋白制备用于乳腺癌患者的内分泌治疗的预后测定的诊断剂和用于乳腺癌和卵巢癌等肿瘤的诊断的诊断剂。 诊断剂包含针对CUEDC2蛋白的抗体,其中抗体是针对CUEDC2蛋白的单克隆或多克隆抗体。 提供了用于乳腺癌患者的内分泌治疗的预后测定和用于乳腺癌和卵巢癌等肿瘤的诊断的试剂盒或组合物。 试剂盒或组合物包含针对CUEDC2蛋白的抗体。 进一步公开了CUEDC2基因或蛋白质在制备用于治疗肿瘤的药物中的用途,即特异性抑制CUEDC2基因\蛋白的表达或活性的小分子物质和特异性抗体用作治疗剂以还原 耐药肿瘤对药物治疗的敏感性。 CUEDC2蛋白的新用途为确定乳腺癌患者外科手术后辅助治疗的剂量方案提供了新的依据,从而提高了抗癌药物的治疗效果,减轻了患者的痛苦和经济负担。
    • 8. 发明授权
    • Molecular marker CUEDC2 protein for prognostic determination of breast cancer endocrinology therapy
    • 分子标记CUEDC2蛋白用于乳腺癌内分泌治疗的预后测定
    • US09200067B2
    • 2015-12-01
    • US13981271
    • 2011-10-28
    • Xuemin ZhangTao ZhouXin PanHuiyan LiAiling Li
    • Xuemin ZhangTao ZhouXin PanHuiyan LiAiling Li
    • G01N33/53C07K16/18C07K16/30
    • C07K16/18C07K16/3015G01N33/57415G01N33/57449G01N2800/52
    • Disclosed is a use of the CUEDC2 protein in the preparation of diagnostic agents for prognostic determination of the endocrinology therapy for the breast cancer patients and for the diagnosis of tumor such as breast cancer and ovarian cancer. The diagnostic agent comprises an antibody against the CUEDC2 protein, wherein the antibody is a monoclonal or polyclonal antibody against the CUEDC2 protein. Provided is a kit or a composition for prognostic determination of endocrinology therapy for the breast cancer patients and for the diagnosis of tumors such as breast cancer and ovarian cancer. The kit or composition comprises an antibody against the CUEDC2 protein. Further disclosed is a use of the CUEDC2 gene or protein in preparation of drugs for treating tumors, that is, small molecular substances and specific antibodies that specifically inhibit the expression or activity of the CUEDC2 gene\protein are used as a therapeutic agent to restore the sensitivity of drug-resistant tumors to drug treatment. The new use of the CUEDC2 protein provides a new basis for determining a dosage regimen of adjuvant therapy after surgical operation of the breast cancer patients, thereby improving the therapeutic effect of the anti-cancer drugs and alleviating the suffering and economic burden of the patients.
    • 公开了使用CUEDC2蛋白制备用于乳腺癌患者的内分泌治疗的预后测定的诊断剂和用于乳腺癌和卵巢癌等肿瘤的诊断的诊断剂。 诊断剂包含针对CUEDC2蛋白的抗体,其中抗体是针对CUEDC2蛋白的单克隆抗体或多克隆抗体。 提供了用于乳腺癌患者的内分泌治疗的预后测定和用于乳腺癌和卵巢癌等肿瘤的诊断的试剂盒或组合物。 试剂盒或组合物包含针对CUEDC2蛋白的抗体。 进一步公开了CUEDC2基因或蛋白质在制备用于治疗肿瘤的药物中的用途,即特异性抑制CUEDC2基因的蛋白质的表达或活性的小分子物质和特异性抗体用作治疗剂以还原 耐药肿瘤对药物治疗的敏感性。 CUEDC2蛋白的新用途为确定乳腺癌患者外科手术后辅助治疗的剂量方案提供了新的依据,从而提高了抗癌药物的治疗效果,减轻了患者的痛苦和经济负担。
    • 9. 发明授权
    • Method for acquiring node information, and client and server
    • 获取节点信息的方法,以及客户端和服务器
    • US08892711B2
    • 2014-11-18
    • US13259178
    • 2010-04-20
    • Bo ChenFei JuLei YuanTao ZhouHanling YangJian Shen
    • Bo ChenFei JuLei YuanTao ZhouHanling YangJian Shen
    • G06F15/173H04W8/20H04W28/06H04W28/04
    • H04W8/20H04W28/04H04W28/06
    • The present invention discloses a method for acquiring node information, and a Client and a server, wherein the method includes: a Client receiving a Get command sent from a server, acquiring values of nodes in all items in the Get command, and determining that acquirement of values of nodes in partial items fails; and the Client sending to the server a response message which carries a new status value, wherein the new status value is adapted to indicate that acquirement of values of nodes in partial items fails when a Get command is executed, and the response message also carries a predetermined tag, wherein the predetermined tag is adapted to packet information of nodes in items in which acquirement of values is successful. By the above technical solution of the present invention, useful nodes can be acquired more effectively, nodes which can not be acquired can be located.
    • 本发明公开了一种获取节点信息的方法,以及客户机和服务器,其中,所述方法包括:客户端接收从服务器发送的获取命令,获取所述获取命令中所有项目中的节点的值,以及确定获取 部分项目节点的值失败; 并且所述客户端向所述服务器发送携带新状态值的响应消息,其中,当执行Get命令时,所述新状态值适于指示部分项中的节点的获取失败,并且所述响应消息还携带 预定标签,其中所述预定标签适用于获取值成功的项目中的节点的分组信息。 通过本发明的上述技术方案,可以更有效地获取有用的节点,可以定位不能获取的节点。